Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
24.73
-0.46 (-1.85%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Moderna Revenue
In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%. Moderna had revenue of $966.00M in the quarter ending December 31, 2024, a decrease of -65.64%.
Revenue (ttm)
$3.24B
Revenue Growth
-52.75%
P/S Ratio
2.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
MRNA News
- 9 days ago - Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - Accesswire
- 12 days ago - Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025 - Accesswire
- 16 days ago - Trump's Tariffs Could Blow Up Big Pharma's Tax Shelter - WSJ
- 17 days ago - Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks - CNBC
- 18 days ago - S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official - Investopedia
- 18 days ago - S&P 500 recoups losses, Dow rises as volatile March ends; Newsmax surges, Moderna tanks - Invezz
- 18 days ago - Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
- 18 days ago - Biotech stocks plunge as FDA's Peter Marks resigns over RFK Jr. dispute, Moderna and Beam Therapeutics hit hard - Invezz